Fresenius Medical Care Corporation

Company Profile

Fresenius Medical Care Corporation had its IPO on 1996-09-19 under the ticker symbol FMS.

The company operates in the Healthcare sector and Medical Care Facilities industry. Fresenius Medical Care Corporation has a staff strength of 124,295 employees.

Stock update

Shares of Fresenius Medical Care Corporation opened at $21.41 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $21.29 - $21.58, and closed at $21.51.

This is a +0.66% increase from the previous day's closing price.

A total volume of 312,105 shares were traded at the close of the day’s session.

In the last one week, shares of Fresenius Medical Care Corporation have slipped by -9.55%.

Fresenius Medical Care Corporation's Key Ratios

Fresenius Medical Care Corporation has a market cap of $12.54 billion, indicating a price to book ratio of 0.5989 and a price to sales ratio of 0.4777.

In the last 12-months Fresenius Medical Care Corporation’s revenue was $19.62 billion with a gross profit of $5.31 billion and an EBITDA of $2.37 billion. The EBITDA ratio measures Fresenius Medical Care Corporation's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Fresenius Medical Care Corporation’s operating margin was 7.52% while its return on assets stood at 2.6% with a return of equity of 5.3%.

In Q2, Fresenius Medical Care Corporation’s quarterly earnings growth was a negative -4.3% while revenue growth was a positive 1.4%.

Fresenius Medical Care Corporation’s PE and PEG Ratio

Forward PE

9.9206

Trailing PE

19.6055

PEG

1.0582

Its diluted EPS in the last 12-months stands at $1.09 per share while it has a forward price to earnings multiple of 9.9206 and a PEG multiple of 1.0582. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Fresenius Medical Care Corporation’s profitability.

Fresenius Medical Care Corporation stock is trading at a EV to sales ratio of 1.2 and a EV to EBITDA ratio of 6.6041. Its price to sales ratio in the trailing 12-months stood at 0.4777.

Fresenius Medical Care Corporation stock pays annual dividends of $1.12 per share, indicating a yield of 3.01% and a payout ratio of 44.46%.

Balance sheet and cash flow metrics

Total Assets

$34.96 billion

Total Liabilities

$6.62 billion

Operating Cash Flow

$-296622000.00

Capital Expenditure

$155.41 million

Dividend Payout Ratio

44.46%

Fresenius Medical Care Corporation ended 2024 with $34.96 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $34.96 billion while shareholder equity stood at $13.53 billion.

Fresenius Medical Care Corporation ended 2024 with $0 in deferred long-term liabilities, $6.62 billion in other current liabilities, 293413000.00 in common stock, $10.64 billion in retained earnings and $15.42 billion in goodwill. Its cash balance stood at $1.36 billion and cash and short-term investments were $1.36 billion. The company’s total short-term debt was $2,257,523,000 while long-term debt stood at $7.00 billion.

Fresenius Medical Care Corporation’s total current assets stands at $8.35 billion while long-term investments were $696.39 million and short-term investments were $0. Its net receivables were $3.65 billion compared to accounts payable of $819.21 million and inventory worth $2.34 billion.

In 2024, Fresenius Medical Care Corporation's operating cash flow was $-296622000.00 while its capital expenditure stood at $155.41 million.

Comparatively, Fresenius Medical Care Corporation paid $0.44 in dividends in 2024.

Other key metrics

Current Trading Price

$21.51

52-Week High

$27.72

52-Week Low

$12.4528

Analyst Target Price

$18.56

Fresenius Medical Care Corporation stock is currently trading at $21.51 per share. It touched a 52-week high of $27.72 and a 52-week low of $27.72. Analysts tracking the stock have a 12-month average target price of $18.56.

Its 50-day moving average was $24.81 and 200-day moving average was $21 The short ratio stood at 2.44 indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 848.2% are held by institutions.